Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
US-2026078091-A1 · Mar 19, 2026 · US
This page is not indexed by search engines while we improve data quality.
Fox Brian M patents
Fox Brian M is listed as an inventor on 41 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Fox Brian M |
| Total patents | 41 |
| First publication | Sep 24, 2015 |
| Latest publication | Mar 19, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Modulators of eukaryotic initiation factor 2b, compositions and methods
US-2025388595-A1 · Dec 25, 2025 · US
Processes of making and crystalline forms of a mdm2 inhibitor
US-2025295647-A1 · Sep 25, 2025 · US
Solid forms of 4-(3,3-difluoro-2,2-dimethyl-propanoyl)-3,5-dihydro-2h-pyrido[3,4-f][1,4]oxazepine-9-carbonitrile
US-2024317776-A1 · Sep 26, 2024 · US
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
US-2024300892-A1 · Sep 12, 2024 · US
Modulators of eukaryotic initiation factor 2
US-2024140919-A1 · May 2, 2024 · US
Compounds, compositions and methods
US-11958840-B2 · Apr 16, 2024 · US
Solid forms of 4-(3,3-difluoro-2,2-dimethyl-propanoyl)-3,5-dihydro-2h-pyrido[3,4-f][1,4]oxazepine-9-carbonitrile
US-2024025915-A1 · Jan 25, 2024 · US
Compounds, compositions, and methods
US-2023416205-A1 · Dec 28, 2023 · US
Modulators of eukaryotic initiation factor 2B, compositions and methods
US-11851440-B2 · Dec 26, 2023 · US
Recent patents
Latest publications not already listed above.
Compounds, compositions and methods
US-2023357162-A1 · Nov 9, 2023 · US
Compounds, compositions and methods
US-2023348437-A1 · Nov 2, 2023 · US
Processes of making and crystalline forms of a mdm2 inhibitor
US-2023301974-A1 · Sep 28, 2023 · US
Modulators of eukaryotic initiation factor 2
US-2023250072-A1 · Aug 10, 2023 · US
Compounds, compositions and methods
US-2023114472-A1 · Apr 13, 2023 · US
Modulators of eukaryotic initiation factor 2B, compositions and methods
US-2022411433-A1 · Dec 29, 2022 · US
Processes of making and crystalline forms of a mdm2 inhibitor
US-2022280496-A1 · Sep 8, 2022 · US
CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
US-11407721-B2 · Aug 9, 2022 · US
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
US-2022169611-A1 · Jun 2, 2022 · US
Compounds, compositions and methods
US-11306077-B2 · Apr 19, 2022 · US
Modulators of eukaryotic initiation factor 2B, compositions and methods
US-11236100-B2 · Feb 1, 2022 · US
Compounds, compositions and methods
US-2021292311-A1 · Sep 23, 2021 · US
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
US-2021179560-A1 · Jun 17, 2021 · US
Compounds, compositions and methods
US-2021147435-A1 · May 20, 2021 · US
Modulators of eukaryotic initiation factor 2
US-2021130308-A1 · May 6, 2021 · US
Processes of making and crystalline forms of a mdm2 inhibitor
US-2020281912-A1 · Sep 10, 2020 · US
Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer
US-2019062276-A1 · Feb 28, 2019 · US
Cis-morpholinone and other compounds as mdm2 inhibitors for the treatment of cancer
US-2018354918-A1 · Dec 13, 2018 · US
Processes of making and crystalline forms of a mdm2 inhibitor
US-2018092898-A1 · Apr 5, 2018 · US
Processes of making and crystalline forms of a MDM2 inhibitor
US-9801867-B2 · Oct 31, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Amgen Inc | 26 |
| Denali Therapeutics Inc | 17 |
| Teijin Pharma Ltd | 2 |
| Amgen Iinc | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 26 |
| C07D401/12 | 22 |
| A61P35/02 | 19 |
| A61K31/451 | 18 |
| C07D211/76 | 18 |